Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.7 USD | +0.79% | +0.31% | +3.05% |
Feb. 28 | Transcript : Sabra Health Care REIT, Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
Feb. 28 | Sabra Health Care REIT Q4 Adjusted FFO, Revenue Decline; Issues 2024 Guidance | MT |
Financials (USD)
Sales 2024 * | 628M | Sales 2025 * | 662M | Capitalization | 3.37B |
---|---|---|---|---|---|
Net income 2024 * | 135M | Net income 2025 * | 152M | EV / Sales 2024 * | 9.36 x |
Net Debt 2024 * | 2.51B | Net Debt 2025 * | 2.5B | EV / Sales 2025 * | 8.87 x |
P/E ratio 2024 * |
25.1
x | P/E ratio 2025 * |
22.6
x | Employees | 48 |
Yield 2024 * |
8.23% | Yield 2025 * |
8.5% | Free-Float | 98.77% |
Latest transcript on Sabra Health Care REIT, Inc.
1 day | +1.89% | ||
1 week | -0.07% | ||
Current month | +5.04% | ||
1 month | +3.92% | ||
3 months | +0.41% | ||
6 months | +6.19% | ||
Current year | +2.17% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Matros
CEO | Chief Executive Officer | 70 | 10-05-09 |
Michael Costa
DFI | Director of Finance/CFO | 45 | 10-10-31 |
Chief Investment Officer | 64 | 10-11-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Foster
BRD | Director/Board Member | 70 | 10-11-02 |
Rick Matros
CEO | Chief Executive Officer | 70 | 10-05-09 |
Craig Barbarosh
BRD | Director/Board Member | 57 | 10-11-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.80% | 227 M€ | +6.90% | - | |
0.23% | 128 M€ | +3.30% | ||
0.15% | 464 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 14.7 | +0.86% | 746 021 |
24-03-27 | 14.58 | +1.89% | 1,659,314 |
24-03-26 | 14.31 | -0.97% | 1,517,540 |
24-03-25 | 14.45 | +1.19% | 1,811,364 |
24-03-22 | 14.28 | -2.59% | 1,735,990 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.17% | 3.37B | |
+2.92% | 52.79B | |
-12.46% | 17.56B | |
-7.53% | 12.99B | |
+1.27% | 7.62B | |
-19.09% | 5.31B | |
+8.09% | 3.27B | |
-10.60% | 2.89B | |
+10.69% | 2.68B | |
-3.87% | 2.83B |